Allele frequency distribution of CYP2C9*2 and CYP2C9*3 polymorphisms in six Mexican populations
Authors:
- Osvaldo D. Castelán-MartínezOCOsvaldo D. Castelán-Martínez
- Carlos Hoyo-VadilloCHCarlos Hoyo-Vadillo
- Emmanuel Sandoval-GarcíaESEmmanuel Sandoval-García
- Lucila Sandoval-RamírezLSLucila Sandoval-Ramírez
- Miriam González-IbarraMGMiriam González-Ibarra
- Gloria Solano-SolanoGSGloria Solano-Solano
- Rita A. Gómez-DíazRGRita A. Gómez-Díaz
- Esteban J. ParraEPEsteban J. Parra
- Miguel CruzMCMiguel Cruz
- Adán Valladares-SalgadoAVAdán Valladares-Salgado
Abstract
No abstract availableKeywords
Funding Information
- Fundación IMSS (99094418)
- CONACyT (17143)
This publication has 46 references indexed in Scilit:
- A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)Circulation, 2012
- Genome-wide patterns of population structure and admixture among Hispanic/Latino populationsProceedings of the National Academy of Sciences, 2010
- Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in MexicoProceedings of the National Academy of Sciences, 2009
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin DosePLOS Genetics, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Adverse drug reactions result in 250 000 UK admissions a yearBMJ, 2006
- DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOSDrug Metabolism and Disposition, 2004
- A novel HLA‐A allele: A*0257†Tissue Antigens, 2003
- Maximum likelihood estimates of admixture in northeastern Mexico using 13 short tandem repeat lociAmerican Journal of Human Biology, 2002
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996